Jones Financial Companies
PRAX icon

Jones Financial Companies’s Praxis Precision Medicines PRAX Stock Holding History

Jones Financial Companies’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.51K Sell
29
-2
-6% -$633 ﹤0.01% 3813
2026
Q1 		$8.99K Buy
+31
New +$9.59K ﹤0.01% 3620
2024
Q3 		– Sell
-152
Closed -$6.29K – 3101
2024
Q2 		$6.29K Buy
+152
New +$7.18K ﹤0.01% 1892

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Jones Financial Companies's PRAX Position: Q2 2026 in Review

Jones Financial Companies reduced its Praxis Precision Medicines (PRAX) stake by 6.5% in Q2 2026, selling an estimated $633 and leaving 29 shares worth $9.51K. The position accounts for ﹤0.01% of the portfolio, ranked #3813.

Jones Financial Companies first reported a position in PRAX in Q2 2024 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Jones Financial Companies held 29 shares of Praxis Precision Medicines worth $9.51K as of Q2 2026.
  • Jones Financial Companies sold 2 Praxis Precision Medicines shares in Q2 2026, an estimated $633.
  • Praxis Precision Medicines made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3813 holding.
  • Jones Financial Companies first reported a position in Praxis Precision Medicines in Q2 2024 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.